WKL Wolters Kluwer NV

Sports Medicine Startup Empericus Teams up With Wolters Kluwer to Transform Athlete Management and Patient Care

today announced that , an innovative, evidence-based platform for patient care and athlete management, has selected Health Language® to accelerate healthcare data exchange in sports medicine. Health Language solutions will strengthen the Empericus real-time Health IntelligenceTM Platform which provides a unified view of an athlete’s complete electronic health record and makes it easy to share with anyone granted access.

“Our mission is to target and bridge the numerous chasms in healthcare resulting from lack of data and poor data collaboration, and Wolters Kluwer is an important partner in that endeavor,” said Ron Pruitt, CEO and founder of Empericus. “With Health Language, we are equipped to provide permissioned individuals, organizations, teams, leagues and schools and other athlete stakeholders with a comprehensive, unified view of all data affecting health and performance. Most importantly, it’s accessible in a way that each can make sense of and quickly act on.”

Empericus is changing the way patients and clinicians can access data across systems. Using Microsoft Azure’s intelligent cloud, Empericus continuously ingests large amounts of data, such as electronic health records, lab results, stress test results, medication regimens and imaging interpretations. Readings from sensor-enabled devices such as wearables and physical training data are also integrated in the Health Intelligence Platform. Health Language is helping transform and unlock the value of that data for better care and better outcomes.

To provide an instantly understandable, visual user experience, takes symptoms, observations, assessments and care plans, standardizes them and maps them to a visual representation of specific body parts/regions.

Providers can more easily search the Empericus platform using clinician terms using . Conversely, to better engage athletes and patients, complex medical jargon is translated by Health Language into simple, easy to understand terms.

Since up to 80% of health data exists in unstructured forms, (cNLP) ensures unstructured text in a patient’s clinical record, such as key problems and diagnoses, can be extracted and visualized on-screen.

“We are excited to support Empericus in their pioneering quest to empower individuals with control of their healthcare data and facilitate a wholly new level of care coordination,” said Karen Kobelski, General Manager of Clinical Surveillance, Compliance & Data Solutions at Wolters Kluwer. “Our solutions will enable the company to simplify management of vast amounts of data, in a way that impacts operational efficiencies and delivers value for both athletes and the clinicians taking care of them.”

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

For more information about our solutions, visit and follow us on and Twitter .

For more information, visit , follow us on , , , and .

EN
12/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wolters Kluwer NV

 PRESS RELEASE

Share Buyback Transaction Details August 28 – September 3, 2025

Share Buyback Transaction Details August 28 – September 3, 2025 PRESS RELEASE                                         Share Buyback Transaction Details August 28 – September 3, 2025 Alphen aan den Rijn – September 4, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 158,600 of its own ordinary shares in the period from August 28, 2025, up to and including September 3, 2025, for €17.0 million and at an average share price of €106.94. These repurchases are part of the share buyback pr...

Wolters Kluwers: 1 director

A director at Wolters Kluwers bought 2,700 shares at 111.300EUR and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

 PRESS RELEASE

Share Buyback Transaction Details August 21 – August 27, 2025

Share Buyback Transaction Details August 21 – August 27, 2025 PRESS RELEASE                                         Share Buyback Transaction Details August 21 – August 27, 2025 Alphen aan den Rijn – August 28, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 138,800 of its own ordinary shares in the period from August 21, 2025, up to and including August 27, 2025, for €15.7 million and at an average share price of €113.22. These repurchases are part of the share buyback program anno...

Jan Frederik Slijkerman
  • Jan Frederik Slijkerman

Wolters Kluwer/New incoming leadership, strong credit profile

Looking at Wolters Kluwer's[de] equity price, the company seems somewhat out of favour with investors. Nevertheless, we like Wolters Kluwer's strong cash generation and credit profile and deem recent M&A transactions favourable. The spread on the notes of Wolters Kluwer looks attractive, in our view.

 PRESS RELEASE

Share Buyback Transaction Details August 14 – August 20, 2025

Share Buyback Transaction Details August 14 – August 20, 2025 PRESS RELEASE                                         Share Buyback Transaction Details August 14 – August 20, 2025 Alphen aan den Rijn – August 21, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 89,500 of its own ordinary shares in the period from August 14, 2025, up to and including August 20, 2025, for €10.1 million and at an average share price of €112.94. These repurchases are part of the share buyback program annou...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch